2020
DOI: 10.2139/ssrn.3546077
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Features of COVID-19-Related Liver Damage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
117
3
8

Year Published

2020
2020
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 83 publications
(132 citation statements)
references
References 0 publications
4
117
3
8
Order By: Relevance
“…ACE2 is localized in various human tissues including the liver [8]. Several clinical studies have shown biochemical evidence of liver injuries [14,15]. However, only limited histologic hepatic abnormalities are noted in our patients.…”
Section: Discussionmentioning
confidence: 69%
“…ACE2 is localized in various human tissues including the liver [8]. Several clinical studies have shown biochemical evidence of liver injuries [14,15]. However, only limited histologic hepatic abnormalities are noted in our patients.…”
Section: Discussionmentioning
confidence: 69%
“…[4][5][6] In a study of 148 infected patients in Shanghai, 50.7% (75/148) had abnormal liver function tests (LFTs). 4 However, 29.7% (44/148) had abnormal LFTs before admission including eight patients with known chronic hepatitis B and C. Pre-existing liver disease in the remaining 36 patients before admission was indeterminate. 14.9% (22/148) of patients with normal tests on admission developed abnormal LFTs, although antiviral therapy may have contributed to this.…”
Section: Covid-19 In Gastroenterology: a Clinical Perspectivementioning
confidence: 99%
“…The clinical presentation and transmission of COVID-19 is complex. Common symptoms include fever, cough, shortness of breath, chest pain, malaise, fatigue, headache, myalgias, anosmia, and diarrhea, while laboratory and radiographic findings include lymphopenia and ground-glass opacities on chest imaging, respectively [1][2][3][4][5][6][7][8] . Of an initial cohort of 1,099 hospitalized patients diagnosed with COVID-19, many developed diffuse alveolar damage (DAD) 1 , pneumonia (79.1%), not infrequently complicated by acute respiratory distress syndrome (ARDS, 3.4%), and shock (1.0%), with 5.0% of patients requiring ICU admission and 2.2% requiring ventilation 4 .…”
Section: Introductionmentioning
confidence: 99%
“…Of an initial cohort of 1,099 hospitalized patients diagnosed with COVID-19, many developed diffuse alveolar damage (DAD) 1 , pneumonia (79.1%), not infrequently complicated by acute respiratory distress syndrome (ARDS, 3.4%), and shock (1.0%), with 5.0% of patients requiring ICU admission and 2.2% requiring ventilation 4 . As the number of patients has surged, multi-system pathologies have been increasingly described, including kidney injury 9 , liver injury, gastrointestinal symptoms 4 , cardiac injury and dysfunction 2,5,10 , and multiorgan failure [1][2][3][4] . In addition to nasal and throat secretions, SARS-CoV-2 RNA has also been detected in saliva and stool specimens 10,11 , suggesting possible alternative routes of transmission beyond respiratory droplets 12, 13 .…”
Section: Introductionmentioning
confidence: 99%